Advances in the pharmacotherapy of Heart Failure: type 2 sodium-glucose cotransporter Inhibitors (SGLT2) as a therapeutic option. RSD [Internet]. 2023 Mar. 1 [cited 2025 Jun. 28];12(3):e12412340502. Available from: https://ojs34.rsdjournal.org/index.php/rsd/article/view/40502